Genetta T, Ruezinsky D, Kadesch T
Howard Hughes Medical Institute, University of Pennsylvania School of Medicine, Philadelphia 19704.
Mol Cell Biol. 1994 Sep;14(9):6153-63. doi: 10.1128/mcb.14.9.6153-6163.1994.
The activity of the immunoglobulin heavy-chain (IgH) enhancer is restricted to B cells, although it binds both B-cell-restricted and ubiquitous transcription factors. Activation of the enhancer in non-B cells upon overexpression of the basic helix-loop-helix (bHLH) protein E2A appears to be mediated not only by the binding of E2A to its cognate E box but also by the resulting displacement of a repressor from that same site. We have identified a "two-handed" zinc finger protein, denoted ZEB, the DNA-binding specificity of which mimics that of the cellular repressor. By employing a derivative E box that binds ZEB but not E2A, we have shown that the repressor is active in B cells and the IgH enhancer is silenced in the absence of binding competition by bHLH proteins. Hence, we propose that a necessary prerequisite of enhancer activity is the B-cell-specific displacement of a ZEB-like repressor by bHLH proteins.
免疫球蛋白重链(IgH)增强子的活性仅限于B细胞,尽管它能结合B细胞特异性转录因子和普遍存在的转录因子。在碱性螺旋-环-螺旋(bHLH)蛋白E2A过表达时,非B细胞中增强子的激活似乎不仅是由E2A与其同源E盒的结合介导的,还由同一位置上阻遏物的取代所介导。我们鉴定出一种“双手”锌指蛋白,命名为ZEB,其DNA结合特异性与细胞阻遏物的相似。通过使用一种能结合ZEB但不能结合E2A的衍生E盒,我们发现该阻遏物在B细胞中具有活性,并且在没有bHLH蛋白结合竞争的情况下,IgH增强子会沉默。因此,我们提出增强子活性的一个必要前提是bHLH蛋白对ZEB样阻遏物的B细胞特异性取代。